Accessibility settings

This paper is in the following e-collection/theme issue:

Health Literacy, Health Numeracy, and Numeracy (53) Involvement of Elderly Populations in Health and Health Services Research (63) Prevention and Health Promotion (1468) Vaccination and Immunization in the Digital Age (456) Influenza and Influenza-Like-Illness (ILI) Surveillance (239) Vaccination Sentiment and Anti-Vaccination Infodemiology (94) Cross-Sectional Studies in Public Health (467)

Published on in Vol 12 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/73940, first published .
Impact of a Free Influenza Vaccination Policy on Older Adults in Zhejiang, China: Cross-Sectional Survey of Vaccination Willingness and Determinants

Impact of a Free Influenza Vaccination Policy on Older Adults in Zhejiang, China: Cross-Sectional Survey of Vaccination Willingness and Determinants

Impact of a Free Influenza Vaccination Policy on Older Adults in Zhejiang, China: Cross-Sectional Survey of Vaccination Willingness and Determinants

Authors of this article:

Yusui Zhao1 Author Orcid Image ;   Jinhang Xu1 Author Orcid Image ;   Xuehai Zhang1 Author Orcid Image ;   Yue Xu1 Author Orcid Image ;   Xiaotong Yan1 Author Orcid Image ;   Shaofan Ren1 Author Orcid Image ;   Lixin Wang1 Author Orcid Image
Article Authors Cited by (3) Tweetations Metrics

Journals

  1. Wang L, Li H, Zhang L, Li D. Changed Trends in Utilization and Substitution Pattern of Non-National Immunization Program Vaccines in Central China, 2011–2024. Vaccines 2025;14(1):16 View
  2. Yan X, Hu X, Xu Y, Zhang X, Zhao Y, Xu J. Herpes zoster vaccination coverage and associated factors among individuals aged ≥50 years in Zhejiang, China: A population-based cross-sectional study. Vaccine 2026;76:128301 View
  3. Yan X, Zhang X, Xu Y, Xu J. Association between vaccination prescription program and herpes zoster vaccine knowledge, intention, and coverage among residents aged ≥50 in Zhejiang Province: Repeated cross-sectional surveys. Human Vaccines & Immunotherapeutics 2026;22(1) View